LBDDS to Bring Poorly Soluble Drugs to Market
Address compounds early on in the development process to reduce costs & attrition rates.
Address compounds early on in the development process to reduce costs & attrition rates.
Have a rigorous and carefully designed plan as to how to handle the compounds safely.
Discover new approach to optimize oral dose development for macromolecules.
Address bioavailability challenges faced in biologic development with a focus on oral delivery.
Strategies for oral formulation selection which can lower attrition rates and more.